Share on LinkedInShare on LinkedIn

ARTICLE · 26 JUNE 2026

GLP-1 Coverage: Solutions For Managing Weight-Loss Drug Costs

Employer-sponsored health plans face mounting pressure from the high costs of GLP-1 weight-loss medications. Bass, Berry & Sims attorneys explore innovative direct-to-consumer programs that bypass traditional pharmacy benefit managers, offering plan sponsors four distinct structural approaches to manage expenses while maintaining compliance and employee access to these increasingly popular treatments.

United StatesEmployment and HR

As GLP-1 medications become an increasingly significant cost driver for employer-sponsored health plans, plan sponsors are seeking creative solutions beyond conventional pharmacy benefit manager (PBM) channels. Direct-to-consumer reimbursement models have emerged as a compelling alternative, enabling participants to obtain these medications at reduced prices while shifting claims processing outside traditional PBM frameworks. Here are key legal and administrative considerations plan sponsors should address before adopting these arrangements.

How Direct-to-Consumer Programs Work

These programs largely operate by removing GLP-1 coverage from the plan’s standard formulary and redirecting participants to a specialized weight management vendor. The vendor conducts medical necessity evaluations, issues prescriptions, and manages ongoing utilization. Participants then fill prescriptions through direct-to-consumer pharmacies, often at prices significantly lower than those negotiated

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from